Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
227,306,614
-
Total 13F shares
-
171,287,734
-
Share change
-
-4,507,019
-
Total reported value
-
$154,952,219
-
Put/Call ratio
-
68%
-
Price per share
-
$0.90
-
Number of holders
-
102
-
Value change
-
-$4,666,477
-
Number of buys
-
42
-
Number of sells
-
39
Institutional Holders of Gossamer Bio, Inc. - Common Stock (GOSS) as of Q4 2024
As of 31 Dec 2024,
Gossamer Bio, Inc. - Common Stock (GOSS) was held by
102 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
171,287,734 shares.
The largest 10 holders included
Octagon Capital Advisors LP, NEA Management Company, LLC, VANGUARD GROUP INC, Alyeska Investment Group, L.P., ARCH Venture Management, LLC, FMR LLC, 683 Capital Management, LLC, Palo Alto Investors LP, SILVERARC CAPITAL MANAGEMENT, LLC, and Samsara BioCapital, LLC.
This page lists
102
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.